193 related articles for article (PubMed ID: 30357045)
1. Identification of Fungal Pathogens in Otomycosis and Their Drug Sensitivity: Our Experience.
Ali K; Hamed MA; Hassan H; Esmail A; Sheneef A
Int Arch Otorhinolaryngol; 2018 Oct; 22(4):400-403. PubMed ID: 30357045
[No Abstract] [Full Text] [Related]
2. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.
Kiakojuri K; Mahdavi Omran S; Roodgari S; Taghizadeh Armaki M; Hedayati MT; Shokohi T; Haghani I; Javidnia J; Kermani F; Badali H; Abastabar M
Mycopathologia; 2021 May; 186(2):245-257. PubMed ID: 33718990
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
Halvaeezadeh M; Jalaee GA; Fatahinia M; Mahmoudabadi AZ
Microb Pathog; 2023 Aug; 181():106180. PubMed ID: 37257666
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic Aspergillus Strains Identification and Antifungal Susceptibility Analysis of 452 Cases with Otomycosis in Jingzhou, China.
Peng D; Li A; Kong M; Mao C; Sun Y; Shen M
Mycopathologia; 2024 Apr; 189(2):30. PubMed ID: 38578519
[TBL] [Abstract][Full Text] [Related]
5. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.
Kamali Sarwestani Z; Hashemi SJ; Rezaie S; Gerami Shoar M; Mahmoudi S; Elahi M; Bahardoost M; Tajdini A; Abutalebian S; Daie Ghazvini R
J Mycol Med; 2018 Jun; 28(2):279-284. PubMed ID: 29540288
[TBL] [Abstract][Full Text] [Related]
6. Otomycosis: The foremost aetiological agent causing otitis externa and the antifungal susceptibility pattern in North-Western Iran.
Roohi B; Nemati S; Alipour A; Faeli L; Mayahi S; Haghani I; Shalchizadeh M; Darini A; Al-Hatmi AMS; Abastabar M; Shokohi T
Mycoses; 2023 Feb; 66(2):87-97. PubMed ID: 36134511
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.
Gharaghani M; Halvaeezadeh M; Ali Jalaee G; Taghipour S; Kiasat N; Zarei Mahmoudabadi A
Curr Med Mycol; 2020 Jun; 6(2):18-22. PubMed ID: 33628977
[TBL] [Abstract][Full Text] [Related]
8. Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China.
Jing R; Yang WH; Xiao M; Li Y; Zou GL; Wang CY; Li XW; Xu YC; Hsueh PR
J Microbiol Immunol Infect; 2022 Apr; 55(2):282-290. PubMed ID: 33839057
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary.
Szigeti G; Kocsubé S; Dóczi I; Bereczki L; Vágvölgyi C; Varga J
Mycopathologia; 2012 Aug; 174(2):143-7. PubMed ID: 22359155
[TBL] [Abstract][Full Text] [Related]
10. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
[TBL] [Abstract][Full Text] [Related]
11. The Role of Candida Albicans in Routine Clinically Suspected Otomycosis.
Amona FM; Wend-Lasida Ouedraogo R; Sangare I; Elola A
West Afr J Med; 2021 Aug; 38(8):743-748. PubMed ID: 34499919
[TBL] [Abstract][Full Text] [Related]
12. Lamisil, a potent alternative antifungal drug for otomycosis.
Zarei Mahmoudabadi A; Seifi Z; Gharaghani M
Curr Med Mycol; 2015 Mar; 1(1):18-21. PubMed ID: 28680976
[TBL] [Abstract][Full Text] [Related]
13. Ear Infections by Non albicans Candida Species with Isolation of Rare Drug Resistant Species in a Tertiary Care Hospital of Bangladesh.
Alam MM; Biplob JA; Sathi FA; Nila SS; Paul A; Khanam J; Chowdhury CS; Khan MS
Mymensingh Med J; 2023 Jul; 32(3):644-648. PubMed ID: 37391953
[TBL] [Abstract][Full Text] [Related]
14.
Singh SK; Patwa DK; Tilak R; Das A; Singh TB
Indian J Dermatol Venereol Leprol; 2019; 85(4):388-392. PubMed ID: 30950409
[TBL] [Abstract][Full Text] [Related]
15. Otomycosis Due to the Rare Fungi Talaromyces purpurogenus, Naganishia albida and Filobasidium magnum.
Aboutalebian S; Mahmoudi S; Okhovat A; Khodavaisy S; Mirhendi H
Mycopathologia; 2020 Jun; 185(3):569-575. PubMed ID: 32232764
[TBL] [Abstract][Full Text] [Related]
16. [Agents of otomycosis in Manisa region, Turkey, 1995-2011].
Değerli K; Ecemiş T; Günhan K; Başkesen T; Kal E
Mikrobiyol Bul; 2012 Jan; 46(1):79-84. PubMed ID: 22399174
[TBL] [Abstract][Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
19. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents.
Nemati S; Hassanzadeh R; Khajeh Jahromi S; Delkhosh Nasrollah Abadi A
Eur Arch Otorhinolaryngol; 2014 May; 271(5):953-7. PubMed ID: 23595615
[TBL] [Abstract][Full Text] [Related]
20. Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study.
Javidnia J; Ghotbi Z; Ghojoghi A; Solhjoo K; Alshahni MM; Jeddi SA; Ahmadi B; Nouripour-Sisakht S; Ansari S; Shokoohi G
Mycopathologia; 2022 Jun; 187(2-3):225-233. PubMed ID: 35347533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
